Abstract:Long non-coding RNA (lncRNA) regulates many physiological processes by acting as competitive endogenous RNA (ceRNA). The dysregulation of lncRNA X-inactive specific transcript ( XIST ) has been shown in various human disorders. However, its role in the pathogenesis of polycystic ovary syndrome (PCOS) is yet to be explored. This study aimed to explore the underlying mechanism of XIST in the pathogenesis of PCOS, specifically through dataset functional analysis. GEO PCOS datasets including RNA-seq, microarray, and miRNA-seq in granulosa cells (GCs) and blood, were examined and comprehensively analyzed. Enrichment analysis, ROC curve constructions, lncRNA-miRNA-mRNA interaction network analyses, and qRT-PCR validation were performed followed by a series of drug signature screenings. Our results revealed significant dysregulation in the expression of 1131 mRNAs, 30 miRNAs, and XIST in GCs of PCOS patients compared to healthy individuals. Of the120 XIST -correlated upregulated genes, 25 were enriched in inflammation-related pathways. Additionally, 5 miRNAs were identified as negative regulators of XIST -correlated genes. Accordingly, a ceRNA network containing XIST -miRNAs-mRNAs interactions was constructed. Furthermore, 6 genes, including AQP9, ETS2, PLAU, PLEK, SOCS3, and TNFRSF1B served as both GCs and blood-based biomarkers. By analyzing the number of interactions among XIST , miRNAs, and mRNAs, we pinpointed ETS2 as the pivotal gene within the ceRNA network. Our findings reveal a novel XIST - hsa-miR-146a-5p, hsa-miR-144-3p, and hsa-miR-1271-5p- ETS2 axis that comprehensively elucidates the XIST -associated mechanism underlying PCOS onset. qRT-PCR analysis further confirmed the, overexpression of both XIST and ETS2 . Furthermore, our results demonstrated that XIST and ETS2 were correlated with some assisted reproductive technologies outcomes. Finally, we identified two novel compounds including, methotrexate/folate and threonine using drug–gene interaction databases for PCOS management. These findings provide novel insights into the molecular etiology, diagnosis, and potential therapeutic interventions for PCOS.

Long non-coding RNA-X-inactive specific transcript inhibits cell viability, and induces apoptosis through the microRNA-30c-5p/Bcl2-like protein 11 signaling axis in human granulosa-like tumor cells

LncRNA XIST Protects Against Polycystic Ovary Syndrome via the Regulation of miR-212-3p/RASA1 Axis

LncRNA SNHG5 Adversely Governs Follicular Growth in PCOS Via Mir-92A-3p/cdkn1c Axis

Long Non-Coding RNA Lnc-CCNL1-3:1 Promotes Granulosa Cell Apoptosis and Suppresses Glucose Uptake in Women with Polycystic Ovary Syndrome

MiR-3940-5p Promotes Granulosa Cell Proliferation Through Targeting KCNA5 in Polycystic Ovarian Syndrome.

Profiles for Long Non-Coding RNAs in Ovarian Granulosa Cells from Women with PCOS with or Without Hyperandrogenism.

MicroRNA-664a-3p inhibits the proliferation of ovarian granulosa cells in polycystic ovary syndrome and promotes apoptosis by targeting BCL2A1

Lncrna GCAT1 is Involved in Premature Ovarian Insufficiency by Regulating P27 Translation in GCs Via Competitive Binding to PTBP1.

MiRNA-335-5p Negatively Regulates Granulosa Cell Proliferation Via SGK3 in PCOS

LncRNA SNHG12 promotes cell proliferation and inhibits apoptosis of granulosa cells in polycystic ovarian syndrome by sponging miR-129 and miR-125b

LncRNA PKD1P6 modulates ovarian granulosa cell survival of hyperandrogenic polycystic ovary syndrome by targeting miR-135b-5p and inhibiting ERK1/2 signaling

Downregulation of Lnc-OC1 Attenuates the Pathogenesis of Polycystic Ovary Syndrome.

Hsa_circ_0043533 modulates apoptosis and viability of granulosa cells via miR-409-3p/BCL2 and EMT signalling in PCOS: Providing novel perspective of metformin

CXCL12 and its receptors regulate granulosa cell apoptosis in PCOS rats and human KGN tumor cells

Discovering therapeutic possibilities for polycystic ovary syndrome by targeting XIST and its associated ceRNA network through the analysis of transcriptome data

Differential expression of long non-coding RNA Regulator of reprogramming and its molecular mechanisms in polycystic ovary syndrome

LncRNA XIST acts as a ceRNA sponging miR-185-5p to modulate pancreatic cancer cell proliferation via targeting CCND2

Lnc-Map3k13-7:1 Inhibits Ovarian GC Proliferation in PCOS Via DNMT1 Downregulation-Mediated CDKN1A Promoter Hypomethylation

Circular RNA circ_RANBP9 exacerbates polycystic ovary syndrome via microRNA-136-5p/ XIAP axis

Inhibition of Long Non-Coding RNA XIST Upregulates Microrna-149-3p to Repress Ovarian Cancer Cell Progression

Long Non-Coding RNA LINC-01572:28 Inhibits Granulosa Cell Growth Via a Decrease in P27 (kip1) Degradation in Patients with Polycystic Ovary Syndrome.